• No results found

Robinson's crown–rump length curve: a major step towards human embryonic health evaluation

N/A
N/A
Protected

Academic year: 2021

Share "Robinson's crown–rump length curve: a major step towards human embryonic health evaluation"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Robinson’s crown

–rump length curve: a

major step towards human embryonic

health evaluation

NIEK EXALTO AND ERIC AP STEEGERS, ERASMUS MEDICAL CENTRE,

ROTTERDAM, THE NETHERLANDS

...

H

uch P. Robinson was the first to pub-lish on crown–rump length (CRL) under ‘preliminary communications’ (BMJ 1973;4:28–31). This was only 10 years after Ian Donald introduced ultrasound and the full bladder technique in obstetrics and gynaecology. For his study in Glasgow, Robinson used a Diasonograph NE 4102 (Nuclear Enterprises), a so-called mechani-cal sector B-scan. This was a ‘black and white’ scan, before the introduction of greyscale and long before real-time ultra-sound. A total of 214 examinations were performed on 80 women (between 6 and 14 weeks of gestation) with certain dates of the last menstrual period and a regular menstrual cycle. In 20 cases of embryonic death, the ‘in utero’ CRL was compared with ‘in vivo’ measurements directly after the miscarriage. A highly significant corre-lation between these values was observed.

Two years later, in 1975, Robinson and Fleming published their revised CRL curve based on 334 measurements, critically evaluating potential sources of random errors (Br J Obstet Gynaecol 1975;82:702– 10). These sources included operator judgement, machine settings and measure-ment from photographs, which was the common procedure in those days. The precision of Robinson’s measurements is

remarkable in the light of the tremendous improvement of the technique since 1975 (Figure 1). It is furthermore amazing that the Robinson Curve has been chosen as one of the four studies with the highest methodological quality scores in a system-atic review of charts (Napolitano et al. BJOG 2014;121:556–65).

Between 1972 and 1979, Robinson was the first to publish on early pregnancy fetal heart rate, ‘gestation sac’ volume, empty sacs, early fetal death, hydatidiform moles and comparisons of CRL measure-ments by real-time and conventional B scanners. Robinson can be regarded as the founder of early pregnancy ultrasound and for initiating Embryonic Medicine.

Encouraged by Robinson, others also pub-lished on this topic. Mantoni and Pederson were the first to describe embryonic growth delay before early fetal death in eight cases of miscarriage (Br J Obstet Gynaecol 1982;89:525–7). Many other studies on the relationship between a small CRL and a higher risk of miscarriage and of structural and chromosomal abnor-malities followed. Measurement of CRL became the worldwide method of choice for pregnancy dating as last menstrual per-iod data have always been subject to recall errors.

In recent Embryonic Health programme studies, using sophisticated CRL measure-ment tools like V-Scope 3D-Virtual Reality– allowing very precise calliper positioning– differences were found between early and late first-trimester embryonic growth coinciding with changes in uterine nourishment from histiotrophic to haemochorial (van Uitert et al. Hum Reprod 2013;28:1753–61) Within this Rotterdam periconception cohort (Predict Study), it was also demonstrated with these techniques that periconceptional character-istics also influence embryonic growth. Larger embryos were seen in older moth-ers, and where there was strong adherence to an energy-rich diet; smaller embryos were seen in the presence of smoking, alcohol use, an adverse cardiovascular risk profile and no folic acid supplementation.

Robinson probably was not aware of the tremendous impact his scientific work would have on contemporary knowledge of early pregnancy physiology and its piv-otal impact on optimising prenatal care.

Disclosure of interests

None declared. Completed disclosure of interests form available to view online as supporting information.&

Figure 1. Technical improvements in first-trimester ultrasound. (A) Robinson 1973 BMJ, sector B-scan, 9 weeks; (B) Robinson 1975 BJOG, sector B-scan, 14 weeks; (C) linear array; (D) greyscale; (E) phased array; (F) 3D/4D view; (G) HD live; (H) V-Scope virtual reality.

1

ª 2018 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists..

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Referenties

GERELATEERDE DOCUMENTEN

Publisher’s PDF, also known as Version of Record (includes final page, issue and volume numbers) Please check the document version of this publication:.. • A submitted manuscript is

Genetic manipulation of hESC and targeting of the cardiac transcription factor Nkx2.5 with EGFP, resulted in a cardiac reporter cell line that was used to

Connecting the dots, advancing human embryonic stem cell biology and cardiogenesis towards functional applications. Copyright 2010,

The availability of human cardiomyocytes from stem cell sources is now expected to accelerate cardiac drug discovery and safety pharmacology by offering more clinically relevant human

To develop a generic method for ectopic gene expression in hESC, we investigated whether twelve independently derived cell lines (HES-2, Envy, HUES1,5,7,15, HESC-NL1,2,3,4 and

The major difference from procedures described by others previously is the use of Matrigel in combination with feeder cell conditioned medium to culture the cells in a true

allows screening of a library of pharmacological candidates, but importantly evaluation of different metastatic cell types, which may be primary cell lines

Dat hangt af van de hoogte van het zakgeld op dit moment en hoe lang er nog zakgeld betaald gaat worden.. Bij een groeipercentage van 30% per jaar hoort een groeifactor